The pandemic outbreak of coronavirus disease 2019 (COVID-19) is rapidly spreading all
over the world. Reports from China showed that about 20% of patients developed severe�…

COVID-19 infection has a heterogenous disease course; it may be asymptomatic or causes
only mild symptoms in the majority of the cases, while immunologic complications such as�…

The coronavirus disease-19 pandemic (COVID-19), which appeared in China in December
2019 and rapidly spread throughout the world, has forced clinicians and scientists to take up�…

Over the 2 months since coronavirus first appeared in China, cases have emerged on every
continent, and it is clear that patients with autoimmune diseases might also be affected�…

Now COVID-19 is causing a severe public health emergency and the mortality is rapidly
increasing all over the world. In the current pandemic era, although there have been many�…

Severe acute respiratory syndrome coronavirus-2, the causative agent of coronavirus
disease 2019 (COVID-19), was declared a pandemic by the World Health Organization on�…

Objectives Severe systemic inflammation associated with some stages of COVID-19 and in
fatal cases led therapeutic agents developed or used frequently in Rheumatology being at�…

The coronavirus disease 2019 pandemic caused by severe acute respiratory syndrome
coronavirus 2 presents with a spectrum of clinical manifestations from asymptomatic or mild�…

Objectives The objective of this study was to estimate the association between tocilizumab
or corticosteroids and the risk of intubation or death in patients with coronavirus disease 19�…

The dysregulated release of cytokines has been identified as one of the key factors behind
poorer outcomes in COVID-19. This “cytokine storm” produces an excessive inflammatory�…